News

Ro Acquires Sperm Analysis and Storage Company Dadi

DTC healthcare company Ro has acquired Dadi, a fertility company specializing in the facilitation of sperm testing, analysis, and storage. The deal follows Ro’s recent $150M raise and another acquisition in the fertility space (Modern Fertility) last summer. As part of the acquisition, today, Ro is launching the Ro Sperm Kit, an updated and rebranded offering powered by Dadi’s proprietary collection, testing,…

Swing Therapeutics Kicks off the Third Study for Its Fibromyalgia Digital Therapeutic 

Fibromyalgia is a condition that causes widespread pain all over the body, sleep problems, fatigue, and often emotional and mental distress. People with fibromyalgia may be more sensitive to pain than people without fibromyalgia. The cause of fibromyalgia is not known, but it can be effectively treated and managed. In the U.S. around 4 million people are affected. Women are twice as…

Vibio Receives The Vegan Society’s Vegan Trademark for Its Full Line of Sexual Wellness Products

Sextech startup Vibio has received The Vegan Society‘s Vegan Trademark and becomes the first sexual wellness company to receive this certification for its toys. All four of Vibio’s vibrators, including Frida, the first toy in the range and the Glee and Wake lubricants are entirely free from animal-products and testing. Both lubes also come in eco-friendly tubes made of 100% sugarcane too.…

Women’s Health Pharma Company ObsEva Sells Regional Rights to Its Uterine Fibroid Drug Linzagolix to Theramex

Women’s health pharma company Theramex and ObsEva, a biopharma company developing and commercializing novel therapies for women’s health have entered into a licensing agreement to commercialize and launch Linzagolix, an oral GnRH antagonist. The launch will be for global markets outside of the U.S., Canada, and Asia. Linzagolix is a GnRH receptor antagonist for the treatment of uterine fibroids. Linzagolix is also…

Contraline Wins “Best Innovation” for ADAM, Its Male Contraceptive, at Reproductive Health Innovation Summit

Male Contraception Startup Contraline has been awarded “Best Innovation” at Reproductive Health Innovation Summit, which took place in Boston on February 15-16. The company’s ADAM System is the world’s first investigational hydrogel implant designed to provide non-hormonal, long-lasting and non-permanent contraception for men Contraline was selected as the winning company among 9 other finalists developing technologies that promote increased reproductive access, choice,…

Femtech Trendwatch: Male Contraceptives, Black Maternal Health & Femtech Investment Round-up February 2022

Every Monday we share a quick “best of” from the week that was with our Inner Circle members. What’s trending in the Femtech Insider community and beyond? We’ve got you covered! In this week’s brief we talk about Male Reproductive Health, plus… Femtech Investment Round-up: Feb 2022 Startups focused on Black Maternal Health And more! Let’s Talk about Male Contraception! Male Contraception Startup Contraline has been…

Femtech Investment Round-up: February 2022

At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is February 2022’s round-up. Investments Virtual eating disorder clinic Equip raises $58M in Series B funding to invest in growth, access & R&D. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To…

Ovia Health Collaborates with the National Birth Equity Collaborative to Launch a New Birth Equity Hub

Family health company Ovia Health is collaborating with the National Birth Equity Collaborative (NBEC), an organization committed to optimizing maternal and infant health on a Black History Month content hub that includes a birth plan series and educational content about birth workers and birth equity designed to empower members of Ovia’s community. Ovia Health was acquired by Labcorp last August and has…